AQEMIA
AI drug invention platform
- B2B
- AI-native
- Has physical offices
- Venture-backed
- Healthtech
- AI & machine learning
- Sales-led purchase
About AQEMIA
Company invents novel drug candidates for major diseases, especially oncology, using a physics-based, generative AI platform, without relying on experimental data.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Revenue
- $10.4M – $82.3MTamtam estimate
- SIREN
- 851519702
- Website
- aqemia.com
- linkedin.com/company/aqemia
AQEMIA at a glance
AQEMIA is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
AQEMIA was founded in 2019.
AQEMIA has 51–250 employees.
AQEMIA's revenue is $10.4M – $82.3M (Tamtam estimate).
AQEMIA's SIREN number is 851519702.
Selling to companies like AQEMIA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies